Wild Wickenburg Bull Riding Fundraising Raises $5K for Teen with MPGN II

In Wickenburg, Arizona, the community sticks together. Community means strength.  So when Noah Ahnlund was diagnosed with a rare autoimmune disease called membranoproliferative glomerulonephritis type II (MPGN II/dense deposit disease)…

Continue Reading Wild Wickenburg Bull Riding Fundraising Raises $5K for Teen with MPGN II
STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum
source: shutterstock.com

STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum

On February 28th, 2024, the first-ever White House Rare Disease Forum took place. Hosted by the White House Office of Science and Technology Policy, this forum provided a platform for…

Continue Reading STXBP1 Disorders Foundation President Charlene Son Rigby on the First White House Rare Disease Forum
Rare Community Profiles: How Beth and Madison Advocated for Public Funding for the First Cystic Fibrosis (CF) Modulator in Canada
source: pixabay.com

Rare Community Profiles: How Beth and Madison Advocated for Public Funding for the First Cystic Fibrosis (CF) Modulator in Canada

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: How Beth and Madison Advocated for Public Funding for the First Cystic Fibrosis (CF) Modulator in Canada

Rare Community Profiles: For Rare Disease Week, Barth Syndrome Advocates Took to Capitol Hill to Urge the FDA to Review NDA for Elamipretide

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: For Rare Disease Week, Barth Syndrome Advocates Took to Capitol Hill to Urge the FDA to Review NDA for Elamipretide